W

arning: Watching TV drug ads may put you to sleep.

That’s no surprise to many of us who’ve heard about the countless ways prescription drugs can harm us. But now, the Food and Drug Administration is considering whether bombarding consumers with every last potential side effect might be overkill. The agency, which approves prescription drugs and oversees how they’re marketed, is proposing a new study to look at whether patients are being “over-warned” to the point that they stop paying attention.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy